Evidence that the reversible MAO-A inhibitor moclobemide increases prolactin secretion by a serotonergic mechanism in healthy male volunteers
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 47 (16) , 1491-1499
- https://doi.org/10.1016/0024-3205(90)90529-z
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- No involvement of α2-adrenoceptors in the regulation of basal prolactin secretion in healthy menPsychoneuroendocrinology, 1990
- Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.British Journal of Clinical Pharmacology, 1989
- A Clinical Study of the Selective MAO-A-Inhibitor Moclobemide (Ro 11-1163): a Comparison of 2 Different Dosages with Particular Reference to Platelet MAO-Activity and Urinary MHPG-ExcretionInternational Clinical Psychopharmacology, 1987
- Hormonal and behavioral effects associated with intravenousl-tryptophan administrationPsychopharmacology, 1986
- A controlled study of a specific MAO a reversible inhibitor (R011-1163) and amitriptyline in depressive illnessJournal of Affective Disorders, 1985
- Moclobemide and clomipramine in the treatment of depression.Acta Psychiatrica Scandinavica, 1984
- A Placebo-controlled Study of the Antidepressant Activity of Moclobemide,A New MAO-A InhibitorPharmacopsychiatry, 1984
- Serotonin Function and Mechanism of Action of Antidepressant TreatmentArchives of General Psychiatry, 1984
- Effect of 1–5 Hydroxytryptophan Infusion on Growth Hormone and Prolactin Secretion in ManJournal of Clinical Endocrinology & Metabolism, 1977
- Stimulation of Human Prolactin Secretion by Intravenous Infusion of L-TryptophanJournal of Clinical Investigation, 1973